Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC

Clinical trial NCT07698106 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07698106
Sponsor: University Health Network, Toronto
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple-Negative Breast Cancer (TNBC)

Start date: 2026-08-01
Primary completion: 2034-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.